Mean number of EBV genomes per cell for each cell subpopulation
| Patient . | Diagnosis . | EBV DNA load/106 cells . | Average number of EBV genomes per cell (range) . | ||||
|---|---|---|---|---|---|---|---|
| B cells . | Plasmablast/plasma cells . | Non-B, non-T, non-monocyte cells . | T cells . | Monocytes . | |||
| 1 | HIV | 12 000 | 22.25 (5-40) | ND | 21 (21) | 0 | 0 |
| 2 | HIV | 4300 | 14.75 (6-23) | 0 | 19 (19) | 0 | 0 |
| 3 | HIV | 18 000 | 12.3 (4-24) | 0 | 21 (21) | 0 | 0 |
| 4 | HIV | 130 000 | 15.75 (1-38) | 9.3 (6-16) | 10.4 (6-15) | 0 | 0 |
| 5 | HIV | 9400 | 10 (10) | 0 | 2 (2) | 14 (14) | 2 (2) |
| 6 | HIV | 5100 | 10.9 (4-20) | 0 | 0 | 0 | 0 |
| 7 | HIV | 22 000 | 10.4 (6-17) | 8.7 (4-16) | 8.75 (6-14) | 0 | 1 (1) |
| 8 | HIV | 6300 | 22.4 (5-35) | 16 (16) | 7 (7) | 0 | 0 |
| 9 | Tx | NA | 7.3 (4-11) | 0 | 0 | 0 | 0 |
| 10 | Tx | 30 000 | 14.25 (6-30) | 0 | 28 (28) | 0 | 0 |
| 11 | Tx | 6200 | 16.2 (2-27) | ND | 3 (3) | 0 | 0 |
| 12 | LyG/HL | 170 000 | 17.8 (4-38) | 0 | 11.2 (7-21) | 8.8 (2-40) | 1.5 (1-2) |
| 13 | Severe primary EBV infection | 280 000 | 17.3 (5-35) | 0 | 9.6 (9-10) | 0 | 0 |
| 14 | PTLD | 1 300 000 | 19.2 (3-35) | 7.5 (3-12) | 13 (7-27) | 0 | 0 |
| 15 | ATL EBV-LPD | 190 000 | 10.7 (2-23) | 8.3 (7-10) | 12.5 (10-15) | 0 | 0 |
| 16 | LyG | 28 000 | 8.26 (2-16) | 3 (3) | 18 (8-34) | 0 | 0 |
| 17 | ICL | 110 000 | 12.9 (3-28) | 0 | 25 (25) | 0 | 0 |
| 18 | AA | 64 000 | 16.5 (7-26) | ND | 7 (7) | 0 | 0 |
| 19 | AA | 110 000 | 14.58 (2-34) | 21 (21) | 0 | 0 | 3 (3) |
| 20 | AA | 6 500 000 | 17.04 (3-35) | 10.8 (4-17) | 12.75 (5-21) | 0 | 0 |
| 21 | B-cell CAEBV | 15 000 | 11.18 (4-22) | 6 (6) | 6.3 (2-9) | 0 | 0 |
| 22 | B-cell CAEBV | 30 900 | 13.17 (4-33) | 0 | 5 (5) | 0 | 0 |
| 23 | B-cell CAEBV | 310 000 | 13.9 (6-23) | 5.5 (5-6) | 6 (6) | 0 | 0 |
| 24 | T-cell CAEBV | 54 666/μg | 0 | ND | 0 | 7.25 (1-22) | 0 |
| 25 | T-cell CAEBV | 67 612/μg | 0 | ND | 0 | 7.66 (1-17) | 0 |
| 26 | T-cell CAEBV | 230 000/μg | 0 | ND | 0 | 10.24 (2-26) | 0 |
| 27 | T-cell CAEBV | 4154/μg | 0 | ND | 0 | 9.88 (3-21) | 0 |
| 28 | IM | 1700 | 12.5 (9-22) | 5 (4-6) | 0 | 0 | 0 |
| 29 | IM | 10 651 | 12.63 (5-27) | 0 | 0 | 0 | 0 |
| Patient . | Diagnosis . | EBV DNA load/106 cells . | Average number of EBV genomes per cell (range) . | ||||
|---|---|---|---|---|---|---|---|
| B cells . | Plasmablast/plasma cells . | Non-B, non-T, non-monocyte cells . | T cells . | Monocytes . | |||
| 1 | HIV | 12 000 | 22.25 (5-40) | ND | 21 (21) | 0 | 0 |
| 2 | HIV | 4300 | 14.75 (6-23) | 0 | 19 (19) | 0 | 0 |
| 3 | HIV | 18 000 | 12.3 (4-24) | 0 | 21 (21) | 0 | 0 |
| 4 | HIV | 130 000 | 15.75 (1-38) | 9.3 (6-16) | 10.4 (6-15) | 0 | 0 |
| 5 | HIV | 9400 | 10 (10) | 0 | 2 (2) | 14 (14) | 2 (2) |
| 6 | HIV | 5100 | 10.9 (4-20) | 0 | 0 | 0 | 0 |
| 7 | HIV | 22 000 | 10.4 (6-17) | 8.7 (4-16) | 8.75 (6-14) | 0 | 1 (1) |
| 8 | HIV | 6300 | 22.4 (5-35) | 16 (16) | 7 (7) | 0 | 0 |
| 9 | Tx | NA | 7.3 (4-11) | 0 | 0 | 0 | 0 |
| 10 | Tx | 30 000 | 14.25 (6-30) | 0 | 28 (28) | 0 | 0 |
| 11 | Tx | 6200 | 16.2 (2-27) | ND | 3 (3) | 0 | 0 |
| 12 | LyG/HL | 170 000 | 17.8 (4-38) | 0 | 11.2 (7-21) | 8.8 (2-40) | 1.5 (1-2) |
| 13 | Severe primary EBV infection | 280 000 | 17.3 (5-35) | 0 | 9.6 (9-10) | 0 | 0 |
| 14 | PTLD | 1 300 000 | 19.2 (3-35) | 7.5 (3-12) | 13 (7-27) | 0 | 0 |
| 15 | ATL EBV-LPD | 190 000 | 10.7 (2-23) | 8.3 (7-10) | 12.5 (10-15) | 0 | 0 |
| 16 | LyG | 28 000 | 8.26 (2-16) | 3 (3) | 18 (8-34) | 0 | 0 |
| 17 | ICL | 110 000 | 12.9 (3-28) | 0 | 25 (25) | 0 | 0 |
| 18 | AA | 64 000 | 16.5 (7-26) | ND | 7 (7) | 0 | 0 |
| 19 | AA | 110 000 | 14.58 (2-34) | 21 (21) | 0 | 0 | 3 (3) |
| 20 | AA | 6 500 000 | 17.04 (3-35) | 10.8 (4-17) | 12.75 (5-21) | 0 | 0 |
| 21 | B-cell CAEBV | 15 000 | 11.18 (4-22) | 6 (6) | 6.3 (2-9) | 0 | 0 |
| 22 | B-cell CAEBV | 30 900 | 13.17 (4-33) | 0 | 5 (5) | 0 | 0 |
| 23 | B-cell CAEBV | 310 000 | 13.9 (6-23) | 5.5 (5-6) | 6 (6) | 0 | 0 |
| 24 | T-cell CAEBV | 54 666/μg | 0 | ND | 0 | 7.25 (1-22) | 0 |
| 25 | T-cell CAEBV | 67 612/μg | 0 | ND | 0 | 7.66 (1-17) | 0 |
| 26 | T-cell CAEBV | 230 000/μg | 0 | ND | 0 | 10.24 (2-26) | 0 |
| 27 | T-cell CAEBV | 4154/μg | 0 | ND | 0 | 9.88 (3-21) | 0 |
| 28 | IM | 1700 | 12.5 (9-22) | 5 (4-6) | 0 | 0 | 0 |
| 29 | IM | 10 651 | 12.63 (5-27) | 0 | 0 | 0 | 0 |